HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Monica Dinulescu Selected Research
Monica Dinulescu Research Topics
Disease
6
Neoplasms (Cancer)
01/2023 - 01/2017
5
Melanoma (Melanoma, Malignant)
01/2023 - 01/2020
2
Merkel Cell Carcinoma
10/2023 - 01/2022
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2021 - 10/2020
1
Hutchinson's Melanotic Freckle (Lentigo Maligna)
09/2023
1
Dysbiosis
01/2022
1
Myositis (Idiopathic Inflammatory Myopathies)
12/2021
1
Squamous Cell Carcinoma of Head and Neck
10/2020
1
Skin Diseases (Skin Disease)
02/2017
1
Drug Hypersensitivity Syndrome
09/2012
Drug/Important Bio-Agent (IBA)
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2023 - 01/2021
2
Immune Checkpoint Inhibitors
IBA
12/2021 - 01/2021
2
N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamide
IBA
01/2021 - 01/2021
2
pembrolizumab
IBA
10/2020 - 01/2020
1
Imiquimod (Aldara)
FDA Link
Generic
09/2023
1
Proton Pump Inhibitors
IBA
01/2023
1
dabrafenib
IBA
01/2023
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2022
1
Oncogene Proteins (Oncogene Protein)
IBA
01/2022
1
cemiplimab
IBA
07/2021
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
01/2021
1
GTP Phosphohydrolases (GTPases)
IBA
01/2021
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2021
1
Antibodies
IBA
01/2021
1
Ligands
IBA
10/2020
1
Ipilimumab
IBA
01/2020
1
Nivolumab
IBA
01/2020
1
Enoxaparin (Lovenox)
FDA Link
Generic
09/2012
Therapy/Procedure
6
Therapeutics
01/2023 - 01/2017
2
Immunotherapy
01/2022 - 01/2020
1
Radiotherapy
10/2023
1
Drug Therapy (Chemotherapy)
10/2020
1
Lasers (Laser)
02/2017